|
|
|
17.04.26 - 22:14
|
′Permanent Scarring′ From Iran War: Goldman′s Rosner (Bloomberg)
|
|
|
Lindsay Rosner, head of multi-sector team at Goldman Sachs Asset Management, joins Katie Greifeld on "Bloomberg Real Yield." Credit investors who gambled on higher-yielding corporate bonds in the midst of the Iran war are looking increasingly vindicated as markets rebound as the Strait of Hormuz reopens. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
17.04.26 - 18:39
|
Goldman Sachs′ 2 Favorite Under-the-Radar Stocks (Benzinga)
|
|
|
Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profitable stock, with a target price of $24. MiniMed produces insulin pump platforms and continuous glucose monitoring technologies, and recently gained FDA approval for its next-generation insulin pump. The global diabetes market is expected to grow significantly, making MiniMed a promising investment opportunity.
Importance Rank:
1
read more...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.04.26 - 09:42
|
Goldman Sachs Says Market Recovery Hinges on ′Rates Relief′ (Bloomberg)
|
|
|
Christian Mueller-Glissmann, head of asset allocation research at Goldman Sachs, discusses the equities rally, the impact of US-Iran de-escalation on sentiment, and whether the markets recovery is sustainable. "I think we need central banks to shift back to a bit to where we were before," Mueller-Glissmann tells Bloomberg Television. "We need the rates relief to come in." (Source: Bloomberg)...
|
|
|
|
|
|
|
|